Abstract 3622: Precision therapy against CRC associated Fusobacterium nucleatum using bioengineered probiotics expressing guided antimicrobial peptides (gAMPs)
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Baylor University
Language: English
Subfield: Food Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148687241
Cites:
Cited by:
Related to: